ASIERIS PHARMACEUTICALS
Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.
ASIERIS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2010-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.asieris.com
Total Employee:
251+
Status:
Active
Contact:
+86 21-68585280-606
Email Addresses:
[email protected]
Total Funding:
1.19 B CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Organization Schema
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Curon Biopharma
Curon Biopharma is a Healthcare company.
Dizal Pharma
Dizal Pharma is a research-based biotechnology company.
GemPharmatech
GemPharmatech is a biotechnology firm.
Genesis Healthcare
Genesis Healthcare is a Japanese genetic testing company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Jinxin Fertility
Jinxin Fertility is a Chinese fertility services provider.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
Homsun Capital
Homsun Capital investment in Series D - Asieris Pharmaceuticals
TriWise Capital
TriWise Capital investment in Series D - Asieris Pharmaceuticals
China Highrun Capital Limited
China Highrun Capital Limited investment in Series D - Asieris Pharmaceuticals
SAIC Capital
SAIC Capital investment in Series D - Asieris Pharmaceuticals
YF Capital
YF Capital investment in Series D - Asieris Pharmaceuticals
Gopher Asset Management
Gopher Asset Management investment in Series D - Asieris Pharmaceuticals
C&D Emerging Investment
C&D Emerging Investment investment in Series D - Asieris Pharmaceuticals
CICC
CICC investment in Series D - Asieris Pharmaceuticals
Haoshuo Zhier Fund
Haoshuo Zhier Fund investment in Series D - Asieris Pharmaceuticals
Xiamen C&D Corporation
Xiamen C&D Corporation investment in Series D - Asieris Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-09 | Asieris Pharmaceuticals Appoints Sophia Cao as Senior Vice President and Head of the Women's Health Business Unit |
Official Site Inspections
http://www.asieris.com Semrush global rank: 6.22 M Semrush visits lastest month: 1.08 K
- Host name: 185.166.146.217.static.a2webhosting.com
- IP address: 185.166.146.217
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Asieris Pharmaceuticals"
Home - Asieris Pharmaceuticals
Improve Human Health to Preserve Patients’ Dignity Leading new drug development for genitourinary tumors & other related diseases Highlights Products Vesique®(APL-1202) | Cevira® (APL-1702) Treatment Areas …See details»
Asieris Pharmaceuticals - LinkedIn
About us Asieris Pharmaceuticals, founded in March 2010, is a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors and other major …See details»
Asieris Pharmaceuticals Headquarters and Office Locations
Asieris Pharmaceuticals Headquarters and Office Locations Asieris Pharmaceuticals is headquartered in Shanghai, 8F Building, 1000 Jinhai Rd, Pudong Xinqu, China, and has 2 …See details»
Asieris’ Subsidiary Baylink Biosciences to Present Two Research ...
Shanghai, China, March 27, 2025 – Asieris Pharmaceuticals (Stock Code: 688176.SH), a global innovative pharmaceutical company focused on genitourinary tumors and women’s health, …See details»
Asieris Pharmaceuticals 2025 Company Profile: Stock …
Information on stock, financials, earnings, subsidiaries, investors, and executives for Asieris Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Asieris Pharmaceuticals Releases 2024 Annual Report, with …
Apr 18, 2025 Asieris Pharmaceuticals today released its 2024 Annual Report, highlighting a bold and determined journey forward. With a specialty pharma strategy and operational efficiency, …See details»
Asieris Pharmaceuticals - Crunchbase Company Profile …
Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.See details»
Asieris Pharmaceuticals - News & Analysis - Crunchbase
Apr 18, 2025 Asieris Pharmaceuticals is a Chinese biotech company.Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections …See details»
Asieris Pharmaceuticals - LifeScienceHistory.com
Asieris Pharmaceuticals is committed to leading the development of new drugs for the treatment of genitourinary tumors and other major diseasesSee details»
Asieris Pharmaceuticals - Financial Details - Crunchbase
Asieris Pharmaceuticals is funded by 27 investors. Homsun Capital and TriWise Capital are the most recent investors. Which investors participated in the most funding rounds?See details»
Asieris Meditech Co., Ltd. - life-sciences-asia.com
Jul 1, 2019 Advertisement Asieris Meditech Co., Ltd. Asieris MediTech Co., Ltd., is a subsidiary of the China-based Jiangsu Yahong Meditech Co., Ltd., a specialty pharma company fully …See details»
Asieris - Products, Competitors, Financials, Employees, …
About Asieris Asieris operates as a global pharmaceutical company focusing on the development of new drugs for genitourinary tumors and other related diseases. The company offers …See details»
Asieris Pharmaceuticals
Feb 25, 2025 Asieris was founded in 2005 by Dr. Francis Chong and Gregory Kao, two experienced biotechnology professionals. Since then, the company has established itself as …See details»
Asieris Presents Phase II Clinical Study Results of APL-1202 in ...
Shanghai, China, February 14, 2025 – Asieris Pharmaceuticals (Stock Code: 688176.SH), a leading global biopharmaceutical company dedicated to advancing innovative therapies for …See details»
Asieris Pharmaceuticals Company Profile - Craft
Asieris Pharmaceuticals is a biotech company that specializes in the development and commercialization of pharmaceutical drugs. It aims to provide treatment for genitourinary …See details»
Asieris Pharmaceuticals - VentureRadar
A China-based clinical stage pharmaceutical with a focus in GU Oncology and Reproductive Health ... Find out more about Asieris Pharmaceuticals, Small Molecule Pharmaceuticals.See details»
Asieris Pharmaceuticals Co., Ltd. - Drug pipelines, Patents
6 days ago Asieris is also enhancing its pipeline for genitourinary diseases via proprietary R&D and strategic partnerships, while closely following cutting-edge technologies and therapeutics. …See details»
Asieris Pharmaceuticals - Executive Bio, Top Executies, and …
View the organization profile of Asieris Pharmaceuticals,Over 20 years of successful track record in biotech start-up, drug R&D, and business development. Founding member of Hutchison …See details»
Asieris Pharmaceuticals - Growth Outlook - Crunchbase
Asieris Pharmaceuticals is a Chinese biotech company.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec et tellus vitae nunc vehicula ullamcorper. Donec sollicitudin tempus …See details»
Asieris Meditech (Hong Kong) Co Ltd - Drug pipelines, Patents, …
Explore Asieris Meditech (Hong Kong) Co Ltd with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 6 news, Disease Domain:Neoplasms, Technology Platform:Small …See details»